MIM
TEVA icon

Marco Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Marco Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-13,340
Closed -$484K – 185
2016
Q4 		$484K Sell
13,340
-6,557
-33% -$262K 0.08% 135
2016
Q3 		$915K Sell
19,897
-400
-2% -$20.9K 0.16% 112
2016
Q2 		$1.02M Sell
20,297
-845
-4% -$45K 0.19% 106
2016
Q1 		$1.13K Hold
21,142
– – 0.16% 100
2015
Q4 		$1.39M Sell
21,142
-850
-4% -$52.5K 0.26% 97
2015
Q3 		$1.24M Sell
21,992
-114
-0.5% -$7.39K 0.25% 98
2015
Q2 		$1.31M Sell
22,106
-514
-2% -$31.7K 0.22% 101
2015
Q1 		$1.41M Buy
22,620
+103
+0.5% +$5.99K 0.24% 93
2014
Q4 		$1.29M Buy
22,517
+2,133
+10% +$119K 0.16% 96
2014
Q3 		$1.1M Buy
20,384
+3
+0% +$159 0.15% 98
2014
Q2 		$1.07M Sell
20,381
-201
-1% -$10.3K 0.2% 99
2014
Q1 		$1.09M Sell
20,582
-597
-3% -$27.6K 0.23% 94
2013
Q4 		$849 Buy
21,179
+700
+3% +$27.6K 0.04% 98
2013
Q3 		$774K Buy
20,479
+2,950
+17% +$115K 0.18% 99
2013
Q2 		$687K Buy
+17,529
New +$683K 0.2% 76

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marco Investment Management's TEVA Position: Q1 2017 in Review

Marco Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 13,340 shares — an estimated $484K sold.

Marco Investment Management first reported a position in TEVA in Q2 2013 and held it in 15 quarters. The position peaked at $1.41M in Q1 2015. 686 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Marco Investment Management reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Marco Investment Management sold 13,340 Teva Pharmaceuticals shares in Q1 2017, an estimated $484K.
  • Marco Investment Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • Marco Investment Management's Teva Pharmaceuticals position peaked at $1.41M in Q1 2015.
  • 686 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on Marco Investment Management's 13F filing for Q1 2017, filed 12 May 2017.